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Historically regarded as an inert sink for
lead, the skeleton is now recognized to be as
important in the kinetic behavior oflead as
are the influences of exposure, absorption,
and elimination (1,2). The skeleton is the
predominant (>90%) endogenous storage
site for lead (3-5). The bulk ofthat lead is
contained within long-lived compartments
ofcortical [elimination half-life (tI,2) >5-10
years] and trabecular (elimination t1/2 >1
year) bone, with comparatively small
amounts of lead in tissue compartments
that rapidly exchange with extracellular
fluid and plasma (1,2,6-8). Because lead is
qualitatively a biologic analog to calcium,
its uptake and release from the skeleton are,
in part, controlled by many of the mecha-
nisms that regulate calcium and bone min-
eral homeostasis (1-13). These include nor-
mal mineral diffusion and turnover (apposi-
tion/resorption) processes (1,2,9-13).
Clinical and experimental studies have
provided evidence that the skeleton may
serve as an endogenous source oflead to the
circulation. This has been suggested to
occur during normal homeostasis (14,15),
after the cessation of chronic occupational
exposures (8,16), during periods ofacceler-
ated bone turnover and mineral loss, such
as in osteoporosis, pregnancy, and lactation
(14,17-19), and under conditions of thy-
roid and parathyroid hormone imbalances
(20,21). Nonetheless, relatively little is
known about the extent to which lead is
mobilized out of bone in environmentally
exposed individuals (22,23), and the infor-
mation that does exist is largely indirect.
The use ofstable lead isotope ratios as a
tracer methodology for evaluating lead
exposure and metabolism is based on dif-
ferences in the relative amounts ofthe four
naturally occurring stable isotopes of lead:
204Pb 206Pb, Pb,Pb, and 208Pb. The natur-
al relative abundances of these isotopes
vary between different geologic sources of
lead, and these isotopic differences persist
when the lead is mined and incorporated
into industrial materials (e.g., gasolines,
paints). Typically, industrial leads contain
a mixture of leads from different geologic
sources as well as recycled lead. Since the
geologic sources of lead used in industrial
materials has changed over the past several
decades, there have also been temporal
changes in the isotopic compositions of
contaminant leads discharged to the envi-
ronment (24-28).
For example, the 207Pb/206Pb ratios in
industrial lead produced and used in the
United States ranged from about 0.862 to
0.983 prior to the late 1960s, since much
of the lead mined at that time came from
geologically. older lead ores with relatively
low amounts of 206Pb (27). The mean
ratio in U.S. leads then began to change
because of the use of younger lead ores
from Missouri, which possessed greater
amounts of206Pb and lower 207Pb/206Pb
ratios (e.g., 0.741) (27). In addition, recy-
cled lead metal contributed substantially to
domestic lead production by the late 1960s,
which also had an impact on the isotopic
compositions of contaminant leads dis-
charged to the environment. As a result, the
isotopic compositions ofhuman lead expo-
sures have changed temporally in the
United States and elsewhere, although it is
difficult to reconstruct those changes in
detail due to the limited amount of avail-
able data.
Stable lead isotope methodologies are
well suited for studying skeletal lead, which
may be distinct from lead in other tissues
(29,30). This is facilitated by the long resi-
dence times of lead in the mammalian
skeleton, which greatly exceed those in the
soft tissues, and by the temporal changes in
the isotopic compositions ofindustrial lead
emissions to the human environment. As a
result, stable lead isotopes may be used to
distinguish circulatory lead derived from
current environmental exposures from
"older" skeletal lead that was assimilated
into bone over past years or decades
(6,14,27,29,30).
Here we report the initial results from a
larger ongoing study to evaluate the skele-
ton as a source oflead to the blood circula-
tion in environmentally exposed human
subjects. In this study, lead concentrations
and stable lead isotopic compositions were
measured in blood and bone samples from
patients undergoing total hip or knee joint
replacement. These initial data will be used
to illustrate both the advantages and limita-
tions ofthis methodology for assessing lead
exposure to humans from multiple sources.
A complete report and discussion of our
results on the extent ofskeletal lead release
for the entire cohort ofthe larger study will
be presented in a subsequent paper when
those data become available.
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Methods
Stable Lead Isotope Ratio
Methodology
The stable lead isotope methodology for
distinguishing multiple sources of lead to
the circulation is based on the occurrence
ofdifferent and measurably distinguishable
lead isotopic compositions of the various
sources. Because this methodology mea-
sures all four stable isotopes (204Pb, 206Pb,
207Pb, and 208Pb) within a sample, it may
be possible to assign isotope ratio signa-
tures as "source-specific" tracers ofdifferent
sources of lead exposure. For the purposes
ofthis article, it is assumed that lead inputs
to the circulation in humans can be simply
represented by sources ofinternal (endoge-
nous) and external (exogenous) origin. We
further assumed that the skeleton is the
main endogenous source oflead, while the
principal exogenous sources of lead expo-
sure in this cohort are from diet, dust, and
water (i.e., ingestion and inhalation). This
two-source model oflead inputs to the cir-
culation is a simplification ofwhat in some
cases may be a complex system with multi-
ple exogenous and endogenous inputs.
Differences in lead isotopic composi-
tions may occur between the skeletal and
circulatory lead pools in humans because of
the long residence times oflead in the skele-
ton and the temporal changes in the isotopic
compositions ofindustrial lead emissions to
the environment (8,14,25-27,29). The
skeleton contains lead accumulated over
approximately the past 20 years ("older" and
often isotopically different lead), whereas the
blood reflects a mixture of recent exposures
and any endogenous bone contribution.
Lead isotopic differences between blood and
bone may be used to evaluate the release of
lead from the skeleton, providing that 1) the
isotopic compositions ofthe primary sources
of lead to the circulation (i.e., endogenous
and exogenous) can be characterized or esti-
mated, and 2) the endogenous and the pri-
mary exogenous sources of lead exposure
have measurably different lead isotopic com-
positions.
Under these conditions, the amount of
lead in the circulation originating from
skeletal versus exogenous sources can be
calculated using three isotope linear regres-
sion analyses (i.e., using ratios with a com-
mon denominator such as 207Pb/206Pb ver-
sus 208Pb/206Pb) (29-31). The isotopically
distinguishable lead in the skeleton and in
the exogenous sources of exposure repre-
sent the two sources of lead input to the
circulation. When the blood is receiving
input predominantly from these two
sources, its isotopic composition will fall
along a "mixing line" defined by those
sources, and the linear distance along that
mixing line will represent the relative con-
tribution of lead from each source to the
lead in blood (Fig. 1).
The relative contribution from each
source (skeletal versus exogenous) to the
lead in the circulation can be calculated
using the following formula:
% Skeletal lead inblood =
207Pb 2 r Pb2
at 206Pb) t206Pb
2 Pb bi Pb
206
Pb
J Pb26
where (207Pb/206Pb)bl = isotope ratio in
blood; (207Pb/206Pb)ex = isotope ratio ofthe
exogenous exposures; and (207Pb/206Pb)b, =
isotope ratio in bone. Although the
207Pb/206Pb ratios were used in this exam-
ple, other ratios such as 208Pb/206Pb can also
be used, as long as the three-isotope regres-
sion is consistentwith the presence ofa two-
source system. Ifonlytwo sources exist, then
using either of the ratios (e.g., 207Pb/206Pb
or208Pb/206Pb) willyield thesame result.
If there is an additional source of lead
that has an isotopic composition different
from the two primary sources, the isotopic
composition of a measured blood sample
will deviate along (or off) the regression line
by a distance proportional to the amount
and isotopic composition of lead that was
derived from that additional source. The
same approach can also applywhen evaluat-
ing how well a suspected lead source (e.g.,
an estimated exogenous exposure) fits a
two-source system defined by a measured
source (bone) and a measured sample mix-
ture (blood).
Subjects
Five subjects (three males, two females, ages
52-75 years) undergoing total hip or knee
arthroplasty within the Orthopedic Surgical
Unit at San Francisco General Hospital
were included in the initial study to assess
the utility ofthe stable isotope methodology
for evaluating bone lead release in environ-
mentally exposed humans. These five sub-
jects were among the first individuals
recruited for the larger ongoingstudy, which
will contain approximately 20 subjects.
Subjects were selected without any apriori
selection/exclusion criteria other than their
need for hip or knee joint replacement. The
subjects gavewritten, informed consent, and
the study was approved by the Committee
on Human Research at the University of
California, San Francisco. A venous whole-
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Figure 1. 207Pb/206Pb versUS 201Pb/206Pb ratios in
paired blood and bone samples from subject 1.
Also included are the isotope ratios of estimated
current lead exposures and past lead exposures
(25). The bone isotopic composition reflects previ-
ous inputs from past lead exposures (blue arrow),
whereas the blood isotopic composition reflects
recent inputs from exogenous (current Pb) and
endogenous (bone) sources (black arrows).
Differences in isotope ratios between paired
blood and bone samples are attributed to the long
elimination halIf-life (t1) of lead in the skeleton
(>1-5 years) compared to lead in the circulation
(<30 days), and to the differences in the lead iso-
topic compositions of current versus past lead
exposures.
blood sample was obtained at the time of
each subject's presurgery examination. Bone
samples were obtained at surgery and were
composed of specimens normally removed
and discarded with total hip or knee arthro-
plasty, as described below.
During patient recuperation in the hos-
pital, a questionnaire was administered to
collect information on each subject's occu-
pational and residential history over the past
20 years to identify specific sources of lead
exposure and to provide a general record of
thesubject's medical and reproductive histo-
ry. One ofthe subjects (#1) had lived in the
San Francisco area >20 years; three (#2, 3,
and 4) had lived in the San Francisco area
12-15 years (previously residing in
Nicaragua, Brazil, and the Philippines,
respectively); and one subject (#5) had lived
in the San Francisco area for only 2 years
(previously residing in Nigeria). The pre-
dominance offoreign-born subjects in this
initial study reflects the ethnic make-up of
the patient population at San Francisco
General Hospital. There was no indication
of excess lead exposure for any of the sub-
jects, based on their reports and occupations
over the past 20 years. Thus, their general
exposure patterns are typical low-level envi-
ronmental lead exposures.
Sample Coliection
We collected venous whole-blood samples
(5 to 7 ml) approximately 5-10 days before
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surgery into vacutainers (royal-blue-top
trace metal, Becton-Dickinson, New
Jersey) containing Na2EDTA as an antico-
agulant. These tubes have been shown to
contain approximately 1 ng Pb as a conta-
minant (32). Bone samples collected at
surgery included the entire head of the
femur (hip arthroplasty, subjects 2 and 3)
or pieces of the femur condyles (knee
arthroplasty, subjects 1, 4, and 5). Both of
those regions are composed largely of tra-
becular bone. The bone samples were
placed into sterile polyethylene containers
at collection. All bone and blood samples
were kept frozen until analyses.
Analyses
We conducted all sample processing and
analyses in a trace-metal-clean HEPA-fil-
tered air (class 100) laboratory using ultra-
clean trace-metal techniques (29). These
techniques are required for clinically or
environmentally based stable lead isotope
tracer studies to avoid sample contamina-
tion and invalidation of the results
(24,29,33,34). Laboratory ware (Teflon,
polyethylene, and polypropylene) and the
titanium and stainless-steel bone-sampling
instruments were acid-cleaned using proce-
dures detailed by Flegal and Smith (33).
Reagents were double sub-boiling quartz
distilled, and water was high-purity grade
(18 MQ-cm).
Aliquots (0.5 ml) ofblood samples were
transferred to Teflon vials, weighed, and
oven dried before acid digestion. We
removed aliquots ofbone from the head or
condyles ofthe femur using a custom-fabri-
cated, hollow titanium alloy drill bit (5.4
mm internal diameter). Bone-core aliquots
were obtained bydrilling through the center
ofthe femur head (anterior-posterior axis) or
piece of condyle. There was no visible sign
ofbone degeneration in any ofthe samples
selected for analyses. Retrieved aliquots of
bone were sequentially trimmed with a
stainless-steel scalpel and rinsed repeatedly
with 1% quartz-distilled HNO3 and ultra-
pure water to obtain afinal analytical sample
from within the bone core. Analytical
aliquots of bone were transferred to Teflon
vials and oven dried (65°C for 3 days) to a
constant weight. Based on previous experi-
ence, as well as concurrent experiments to
evaluate lead contamination, this bone sam-
pling procedure yielded an uncontaminated
aliquot composed largely oftrabecular bone.
Dried blood and bone samples were
digested in hot 16 N HNO3 for about 8
hr, evaporated to dryness, and redissolved
in 1 N HNO3 (29). We measured lead
concentrations in sample aliquots by
graphite furnace atomic absorption spec-
trometry (GFAAS), using the method of
additions to minimize matrix interferences
(29). Procedural accuracy of the lead con-
centration measurements was quantified by
concurrent analyses of National Institutes
of Standards and Technology Standard
Reference Material 955a (blood). The ana-
lytical limit of quantitation of lead by
GFAAS was 0.02 pg/dI.
After measuring lead concentrations,
we processed aliquots of digested samples
for lead isotopic composition analyses
using an anion-exchange resin separation
technique (29). Lead isotopic compositions
were measured by thermal ionization mass
spectrometry (TIMS) using a VG Sector
354 multicollector instrument. Total
cumulative lead (mean ± coefficient ofvari-
ation) in procedural (processing and analy-
ses) blanks was determined to be 60 pg ±
30% by isotope dilution TIMS. This blank
amount was <1% ofthe lead content ofthe
lowest lead sample aliquot analyzed. Blank
corrections of the isotopic ratios and the
analyses ofpropagated errors were calculat-
ed using methods described previously
(29). The final propagated error ofthe iso-
tope ratio measurements was <0.02% rela-
tive standard error (RSE).
We determined the relative amount
(percent) oflead in the circulation that was
derived from the skeleton using the formula
presented above. The percentage ofskeletal
lead in blood was calculated using both
207Pb/206Pb and 208Pb/206Pb ratios, and
those two results were averaged (mean ±
SD). The major isotope ratios, 207Pb/206Pb
and 208Pb/206Pb (isotopes ofgreater natural
relative abundance), were used for these cal-
culations, rather than ratios with the minor
isotope 204Pb, because the former can be
measured with greater precision and has
proven more useful in distinguishing lead
sources (24,29,35).
We hypothesized that the isotopic com-
position of the current "net" exogenous
exposure for these subjects could be charac-
terized by the lead in local particulate
aerosols and tap water. Therefore, we quali-
tatively derived an estimate ofthis exposure
using the isotopic compositions (i.e.,
207Pb/206Pb, 208Pb/206pb, 206Pb/204Pb,
207Pb/204Pb, and 208Pb/204Pb) ofpreviously
measured urban aerosols/dusts and tap water
samples -from the San Francisco area
(28,36). Current exposure values extrapolat-
ed from the regression lines defined by the
subjects' blood-bone pairs were also incor-
porated into this estimate (see Discussion).
Results
The levels oflead in the blood (1-6 pg/dl)
and bone (0.6-7 pg/g dry weight) ofthese
subjects were relatively low, and levels var-
ied between subjects (Table 1). These data
indicate an absence ofrecent or chronically
elevated past lead exposures, which is con-
sistent with the questionnaire results ofthe
subject's residence and occupation history
over the past 20 years. Based on current
models of lead exposure (37), their princi-
pal sources ofexposure were from environ-
mental lead, including lead in urban dusts,
food, water, and particulate aerosols.
There were relatively large differences
between the lead isotopic compositions of
the paired blood and bone samples for each
ofthe subjects, with bone exhibiting notably
larger 207Pb/206Pb and 208Pb/206Pb ratios in
all cases (Table 1; Fig. 2). The isotopic dif-
ferences between paired blood and bone
samples (e.g., 0.4-0.9% for 207Pb/206Pb
ratios) were easily discernible with TIMS
Table 1. Lead concentrations and stable lead isotopic compositions in paired blood and bone samples and
the calculated relative percentofthe lead in blood derived from the skeleton
Subject Pb Bone-derived
no. Age/sex Sample concentrationa 207Pb/Pbb 2ffPb/P6Pb MPb/20Pb Pb in bloodc
1 61/M Blood 3.4 0.8474 (0.0002) 2.073 (0.001) 18.462 (0.010) 61 ± 8
Bone 6.3 0.8550 (0.0000) 2.082 (0.001) 18.232 (0.007)
2 52/F Blood 1.3 0.8400 (0.0000) 2.063 (0.001) 18.646 (0.021) 42 ± 24
Bone 0.74 0.8460 (0.0000) 2.069 (0.001) 18.526 (0.016)
3 58/M Blood 5.7 0.8563 (0.0002) 2.088 (0.001) 18.224 (0.009) 71 ± 1
Bone 6.9 0.8634 (0.0002) 2.102 (0.001) 18.060 (0.007)
4 75/M Blood 3.1 0.8510 (0.0002) 2.074 (0.001) 18.352 (0.011) 72± 2
Bone 1.4 0.8564 (0.0001) 2.081 (0.001) 18.200 (0.009)
5 69/F Blood 2.8 0.8648 (0.0002) 2.108 (0.001) 18.012 (0.011) -d
Bone 0.65 0.8680 (0.0001) 2.117 (0.001) 17.997 (0.011)
aBlood and bone lead concentrations in units of pg Pb/dl blood and pg Pb/g dry bone, respectively.
bisotope ratio errors in parentheses are 2 SEs of measurement bythermal ionization mass spectrometry.
cValues are averages (±SD) of results calculated using the 207Pb/206Pb and 208Pb/206Pb ratios (see
Methods).
dUnable to calculate forthis subject because the estimate of current exposure derived for the other four
subjects did not appear to adequately represent the predominant source of exogenous exposure to this
individual (see Results).
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because they exceeded the isotope ratio error
of measurement (<0.02% RSE) by 20-fold
to >40-fold. There were also substantial dif-
ferences in the blood and bone isotopic
compositions between the subjects.
The differences in isotopic composi-
tions between the blood-bone sample pairs
from each subject are attributed to differ-
ences in the lead isotopic compositions of
current versus past lead exposures and to
the long elimination half-life oflead in the
skeleton compared to lead in the circula-
tion. This is illustrated in Figure 1 using
the data ofsubject 1. His skeleton appears
to contain a relatively large component of
"older" or previously accumulated lead,
based on its similarity to the isotopic com-
position of urban dusts/aerosols and gaso-
line from California (Los Angeles) several
decades ago (25). In contrast, the blood
isotopic composition ofthis subject (as well
as that of other subjects) more closely
resembles current urban leads in the San
Francisco area (28,36).
The relative amount of lead in blood
that was derived from the skeleton was cal-
culated for each of the subjects using the
isotopic compositions measured in their
blood and bone samples and an estimated
isotopic composition of their current net
exogenous exposure of 207Pb/206Pb =
0.8380, 208Pb/206Pb = 2.0545, and
206Pb/204Pb = 18.660. As mentioned above,
this estimate ofcurrent exogenous exposure
was qualitatively derived using the isotopic
compositions ofpreviously measured urban
aerosols/dusts and tap water from the San
Francisco area (28,36) and current exposure
values extrapolated from the regression lines
defined by the subjects' blood-bone pairs.
This estimate is includedwith an uncertain-
tyoval (95% confidence limits) in Figures 1
and 2. The isotopic composition of their
current exogenous exposure was determined
indirectly because ofthe limitations and dif-
ficulty associated with directly measuring all
possible sources ofexposure and then evalu-
ating the relative contributions of those
sources to the lead assimilated into blood.
Using three-isotope linear regression
analyses, the relative amount (percent) of
lead in blood that was derived from the
skeleton (mean ± SD, using both the
207Pb/206Pb and 208Pb/206Pb ratios) was
determined to be 61% ± 8%, 42% ± 24%,
71% ± 1%, and 72% ± 2% for subjects 1,
2, 3, and 4, respectively (Table 1). We did
not calculate the bone lead contribution to
blood for subject 5 (a recent immigrant
from Nigeria), since the estimate ofcurrent
exogenous exposure derived for the other
four subjects did not appear to represent the
predominant source ofexogenous exposure
for this individual. This was apparent when
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Figure 2. (A) 207Pb/206Pb versus 208Pb/206Pb ratios and (B) 206Pb/204Pb versus 208Pb/204Pb ratios in paired
blood and bone samples from the five subjects (paired blood-bone samples for each subject are connect-
ed by a solid line; subject number listed beside each symbol). Also included is the estimated current lead
exposure (surrounding oval indicates 95% confidence limits) for subjects 1-4. The estimate of current lead
exposure does not adequately represent the predominant source of exogenous exposure to subject 5,
based on the 206Pb/204Pb and 208Pb/M'Pb ratios in her blood (i.e., her blood lead isotopic composition is not
directionally oriented toward the current lead exposure isotopic composition). This was not evident from
the 207Pb/206Pb and 208Pb/206Pb ratios. The typical errors are 2 SEs of measurement by thermal ionization
mass spectrometry.
the 206Pb/204Pb and 208Pb/204Pb ratios
were considered (Fig. 2B) and was not evi-
dent from the plot of 207Pb/206Pb versus
208Pb/206Pb ratios (Fig. 2A). We could not
estimate the alternate sources ofexogenous
exposure for subject 5, who may have
dietary or other habits that contribute to a
unique lead exposure.
Discussion
Many urban-dwelling adults aged 25 years
and older are likely to have elevated bone
stores oflead, due to the lack ofregulation
of lead sources in the United States and
elsewhere before the mid-1970s.
Subsequent regulation of several major
sources of lead exposure (e.g., lead in
industrial emissions, gasoline, paint, and
solder) has contributed to declines in blood
lead levels in the United States and in sev-
eral other countries (38,39). Consequently,
the importance of elevated burdens of
endogenous lead within the skeleton rela-
tive to exogenous environmental exposures
may be increased in this cohort.
The results ofthis initial study are con-
sistent with that concern. They indicate
that previously accumulated lead stores
within the skeletons of these environmen-
tally exposed subjects are serving as impor-
tant sources of lead by contributing
40-70% ofthe lead in the circulation. The
differences in bone isotopic compositions
between the subjects reflect the different
sources of past exposures and possibly dif-
ferent rates of exchange of accumulated
bone lead with isotopically different lead in
the circulation. These data are consistent
with a study by Manton (14), who used a
similar methodology to estimate that the
skeleton contributed as much as 70% of
the lead in the circulation ofan adult male.
This stable isotope methodology offers
several important advantages over other cur-
rently available methods to evaluate skeletal
lead release. It is capable ofidentifying and
distinguishing circulatory lead derived from
the skeleton from lead derived from exoge-
nous sources. Very small (<0.1%) differ-
ences in the isotopic compositions of lead
can be measured by TIMS because of its
sensitivity (<1 ng sample lead) and isotope
ratio measurement precision (.0.02% RSE)
(29,30). These properties ofTIMS are supe-
rior to inductively coupled plasma (quadra-
pole) mass spectrometry (ICPMS), which
has a typical isotope ratio measurement pre-
cision ofabout 0.5% relative standard devia-
tion for the major lead isotope ratios in
blood (40,41). Thus, in many cases ICPMS
may not reliably distinguish sample isotopic
compositions that differ by less than 1%, as
occurred between thepaired blood and bone
samples in this study.
The method used to calculate the
amount of lead in blood that was derived
from the skeleton deserves additional dis-
cussion. As previously noted, the relative
amount ofskeletal lead (mean ± SD) in the
circulation was calculated using both the
207Pb/206Pb and 208Pb/206Pb ratios (Table
1). This may provide a better estimate of
that value in cases where an ideal two-
source system does not exist or when the
isotopic composition of one of the lead
sources is notwell known.
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For example, when the estimated iso-
topic composition ofthe current exogenous
exposure nearly falls on the line defined by
the blood-bone pair (e.g., subject 3, Fig. 3),
then essentially the same value is obtained
for the percent bone lead contribution to
blood lead (72% versus 71%) by using the
207Pb/206Pb versus the 208Pb/206Pb ratios.
However, different results for the bone lead
input to blood are obtained by using the
207Pb/206Pb versus the 208Pb/206Pb ratios
when the estimated isotopic composition of
the current exposure is a poorer approxima-
tion of the net exogenous exposure for a
subject. This latter example is the case for
subjects 1 and 2. This is also illustrated in
Figure 3, where subject I's bone lead con-
tribution to blood was calculated to be 55%
and 67% based on the 207Pb/206Pb and
208Pb/206Pb ratios, respectively.
However, using both the 207Pb/206Pb
and 208Pb/206Pb ratios may not always pro-
vide a better estimate ofthe bone lead input.
When the estimated lead isotopic composi-
tion of the current exogenous exposure falls
on the blood-bone line, but at apointdiffer-
ent from the "true" (unknown) exogenous
exposure, using both ratios will yield the
same result for the percent bone lead contri-
bution to blood lead. However, the result
will be biased by an amount proportional to
the difference between the estimated current
exogenous exposure and the "true" exposure.
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Figure 3. Example of the method used for calcu-
lating the relative amount of lead in blood that
was derived from bone. Included are the paired
blood and bone samples from subjects 1 and 3,
and their estimated current exogenous exposure
(uncertainty oval omitted). Here, the estimated
isotopic composition of the exogenous exposure
appears to be a relatively good approximation of
that exposure for subject 3 (i.e., it nearly falls on
the dashed line defined by his blood-bone pair).
In contrast, the estimated exogenous exposure
appears to be a relatively poor approximation of
the exposure for subject 1, so that different
results for the bone lead input to blood are
obtained by using the 207Pbf206Pb (point A) com-
ni nn---inn pae to the s 0P/0P (pontB) atosse
Discussion).~|_
The isotopic composition of the cur-
rent net exogenous exposure was qualita-
tively derived from the isotopic composi-
tions of previously measured urban
aerosols/dusts and tap water samples from
the San Francisco area (28,36) and from
current exposure values extrapolated from
the regression lines defined by the
blood-bone pairs ofsubjects 1, 2, 3, and 4.
This derivation of the current exogenous
exposure is justified by the importance of
urban aerosols/dusts as both a direct and
indirect source of lead to humans and
other organisms (14,28,35-37,42-45). It
is also justified by assumptions inherent to
the two-source mixing model. The lead
sources and a sample mixture (i.e., blood)
containing some amount of each lead
source should fall along a common line
when the data are expressed on a three-iso-
tope plot (29,31). However, because this
value for current exposure is a composite
estimate, it may not exactly reflect the true
current net exposure for each of the sub-
jects that is indicated bythe line extrapolat-
ed from their blood-bone pair (Fig. 3).
Although it is apparent that the lead
contained in the skeletons ofthese subjects
has been accumulated from exposures years
or decades earlier, it is not possible to deter-
mine how much of their current skeletal
lead burden was derived from past com-
pared to more recent exposures. In other
words, it is not possible to say how much
"older" lead is contained in their skeletons.
This is because little is known about the
subjects' past exposure history to lead in
regard to its isotopic composition; there are
relatively few data on the isotopic composi-
tions of industrial lead emissions in the
United States or elsewhere over past
decades. In the case ofsubject 1 (Fig. 1), we
used the data ofChow and Johnstone (25)
as an example ofthe isotopic compositions
ofindustrial lead that may have served as a
source of exposure decades earlier.
However, it is likely that the isotopic com-
positions of past lead exposures have been
both spatially and temporally variable
(14,27). Similar arguments can also be
made for any of the other four subjects.
Nonetheless, the skeletons ofall the subjects
contained 207Pb/206Pb and 208Pb/206Pb
ratios that were larger than in their paired
blood samples, indicating that the lead
accumulated in their skeletons from past
exposures was less radiogenic (i.e., lower rel-
ative amounts of the isotope 206Pb) than
the more recent exogenous exposures.
The subjects recruited for this study
underwent total hip or knee arthroplasty
due to degenerative joint disease/ osteoarth-
ritis ofthe hip or knee joint. The influence
ofthis pathology on the lead content ofthe
analyzed bone specimens or on the release
of lead from bone are not known. It has
been suggested that the amount of lead
released from bone back into the circulation
may be increased during periods of
increased bone turnover and/or net resorp-
tion, such as may occur during physiologic
stresses (e.g., pregnancy, lactation, dietary
mineral deficiency) and disease (e.g., hyper-
parathyroidism) (17-21,46). Therefore,
the large amount ofbone-derived lead con-
tained in the circulation of these subjects
might reflect a relative increase in bone lead
release due to degenerative joint
disease/osteoarthritis.
The health risks associated with lead
released from the skeleton are not known.
In children, toxic effects oflead on the cen-
tral nervous system have been shown to
occur at relatively low exposures (47-50),
and there is still no established lower
threshold for lead toxicity (48,51,52).
Unfortunately, no similar data have been
produced for populations prone to
increased bone mineral loss, such as the
elderly.
This stable lead isotope methodology is
qualified by the confounding effects of iso-
topic variability and heterogeneity in the
exogenous and endogenous sources of lead
exposure. As illustrated in Figure 3, uncer-
tainty or variability in the isotopic composi-
tion ofa lead source (e.g., current exogenous
lead exposure) increases the uncertainty in
the calculated relative proportion of that
source contained in the sample mixture
(blood). Isotopic heterogeneity within the
skeleton (either intra-trabecular or between
trabecular and cortical bone) may also con-
tribute to a biased assumption of the iso-
topic composition of lead in bone when
only a representative sample is measured.
This bias may introduce error in the calcu-
lated bone lead input to blood, resulting in
an over- or underestimate of that value
depending on the effective isotopic compo-
sition ofthe sampled bone compared to the
skeleton as a whole and any relative differ-
ence in the rate ofbone lead release between
the measured bone and thewhole skeleton.
The potential magnitude of this bias
can be illustrated using the data ofsubject
1. If cortical bone contains 207Pb/206Pb
and 208Pb/206Pb ratios that are approxi-
mately 1% larger than the ratios of0.8550
and 2.082 measured in trabecular bone
(reflecting a greater proportion of "older"
lead contained in cortical bone) (27), and
trabecular and cortical bone contributed
equally to the lead in circulation, then the
calculated bone lead input to blood for
subject 1 would be 49% rather than the
61% reported here. This may be an overes-
timate of the potential bias, since trabecu-
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lar bone may contribute more lead to the
circulation than cortical bone under steady-
state conditions, based on the 2- to 5-fold
greater blood perfusion and turnover rates
of trabecular versus cortical bone
(6,53,54).
There may be ambiguity concerning
bone as an endogenous source of lead to
the circulation. This ambiguity arises large-
ly from the complex nature ofbone physi-
ology and lead kinetics within the skeleton.
Although bone functions as a long-term
storage site for lead, there is also believed to
be short-term (<days) exchange of lead
between bone and the circulation associat-
ed with bone surfaces, intermediate
(<months) exchange associated with the
bone volume, and long-term (years)
exchange associated with diffusion and
bone turnover (apposition/resorption)
processes (1,2). It is not possible to identify
the relative contribution of these specific
"compartments" or processes to the release
oflead from bone using the stable isotope
methodology as applied here. Rather, these
data likely reflect the net physiologic
process contributing to bone lead release.
Summary
This initial study demonstrates the utility
and limitations of the stable isotope
methodology for evaluating the release of
lead from bone in humans. The skeleton is
an important endogenous source of lead
exposure in environmentally exposed sub-
jects. However, the small number and med-
ical condition (degenerative joint
disease/osteoarthritis) of the subjects pre-
sented here may limit the extrapolation of
these results to the general population. More
extensive studies with a larger cohort are in
progress to better identify the isotopic signa-
ture of exogenous exposures, as well as the
spatial heterogeneity in bone lead isotopic
compositions within individuals. Those data
will allow us to evaluate with greater accura-
cy and certainty the role ofthe skeleton as a
source oflead exposure in humans.
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